IMS
EBS icon

Index Management Solutions’s Emergent Biosolutions EBS Stock Holding History

Index Management Solutions’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-11,209
Closed -$252K – 1096
2014
Q2 		$252K Buy
11,209
+7,771
+226% +$181K 0.03% 508
2014
Q1 		$87K Buy
+3,438
New +$86.8K 0.01% 512

Other funds holding EBS

Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
GC
Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Index Management Solutions's EBS Position: Q3 2014 in Review

Index Management Solutions sold out of Emergent Biosolutions (EBS) in Q3 2014, closing a stake of 11,209 shares — an estimated $252K sold.

Index Management Solutions first reported a position in EBS in Q1 2014 and held it in 2 quarters. The position peaked at $252K in Q2 2014. 162 funds tracked by Wall St. Rank hold EBS as of Q3 2014.

  • Index Management Solutions reported no remaining Emergent Biosolutions position as of Q3 2014 after selling out during the quarter.
  • Index Management Solutions sold 11,209 Emergent Biosolutions shares in Q3 2014, an estimated $252K.
  • Index Management Solutions first reported a position in Emergent Biosolutions in Q1 2014 and held it in 2 quarters.
  • Index Management Solutions's Emergent Biosolutions position peaked at $252K in Q2 2014.
  • 162 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2014.

Based on Index Management Solutions's 13F filing for Q3 2014, filed 13 Nov 2014.